Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$13.95 - $19.28 $326,639 - $451,441
23,415 New
23,415 $420,000
Q3 2022

Nov 14, 2022

SELL
$14.66 - $18.3 $106,226 - $132,601
-7,246 Reduced 16.89%
35,665 $604,000
Q2 2022

Aug 15, 2022

SELL
$14.1 - $20.26 $53,664 - $77,109
-3,806 Reduced 8.15%
42,911 $679,000
Q1 2022

May 11, 2022

BUY
$15.23 - $21.47 $73,073 - $103,013
4,798 Added 11.45%
46,717 $940,000
Q4 2021

Feb 11, 2022

SELL
$21.65 - $27.0 $15,284 - $19,062
-706 Reduced 1.66%
41,919 $941,000
Q3 2021

Nov 12, 2021

BUY
$19.51 - $28.7 $831,613 - $1.22 Million
42,625 New
42,625 $1.08 Million

Others Institutions Holding STVN

About Stevanato Group S.p.A.


  • Ticker STVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 264,700,000
  • Market Cap $5.44B
  • Description
  • Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machine...
More about STVN
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.